Ledger.Open graph →
SEC Form D · filed December 17, 2020

Avilar Therapeutics, Inc

Offering
$60.0M
Sold
$20.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Joshua Resnick · Boston, MADirectorMilind Deshpande · Boston, MAExec · DirectorDavid Neafus · Cambridge, MAExecTom B. Orradre · Newport Beach, CADirectorShawn M. Stasko · Lexington, KYExec · DirectorTheresa Cameron · Boston, MADirectorJay W. Trulove · Berryville, ARDirectorMenno E. Ellis · Rock Hill, SCExec · DirectorTheresa Cameron · Boston, MADirectorDavid Neafus · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗